Literature DB >> 19950775

Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: prospective randomized study.

Yutaka Asakuma1, Masatoshi Kudo, Shigenaga Matsui, Mumon Okada, Masanori Kawasaki, Yasushi Umehara, Tsutomu Ichikawa, Satoshi Kitai.   

Abstract

BACKGROUND/AIMS: Ecabet sodium (ES) is a widely employed mucoprotective agent, for the treatment of gastric ulcers. The present paper prospectively evaluate the additive benefits of using ES in combination with the rabeprazole proton pump inhibitor (PPI) for the treatment of gastric ulcers after endoscopic submucosal dissection (ESD).
METHODOLOGY: A total of 56 patients who had undergone ESD for early gastric cancers were randomly assigned to receive either PPI with ES (P/ES group, n=28) or PPI alone (PPI group, n=28) for 8 weeks. At 4 and 8 weeks after ESD, the healing rate and the diminution rate of the ulcers were compared between two groups by endoscopy.
RESULTS: One patient in the PPI group developed a hemorrhage as a result of an ESD-induced ulcer. At 4 weeks, the healing rates were significantly higher in the P/ES group (40.7%) compared with the PPI group (11.5%), (p = 0.0013). This tendency was observed also at 8 weeks (p = 0.0446). In addition, at 4 weeks, the diminution rates of the ESD-induced ulcers were significantly higher in the P/ES group (95.8%) than in the PPI group (84.9%), (p=0.0033).
CONCLUSIONS: ES in combination with PPI facilitates increased healing of ESD-induced ulcers, and can also improve the quality of ulcer healing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19950775

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  13 in total

1.  Management of bleeding and artificial gastric ulcers associated with endoscopic submucosal dissection.

Authors:  Yosuke Muraki; Shotaro Enomoto; Mikitaka Iguchi; Mitsuhiro Fujishiro; Naohisa Yahagi; Masao Ichinose
Journal:  World J Gastrointest Endosc       Date:  2012-01-16

2.  Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study.

Authors:  Suck-Ho Lee; Chang Kyun Lee; Il-Kwun Chung; Yun Suk Shim; Tae Hoon Lee; Sae Hwan Lee; Hong-Soo Kim; Sang-Heum Park; Sun-Joo Kim
Journal:  Dig Dis Sci       Date:  2011-10-15       Impact factor: 3.199

3.  A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection.

Authors:  Shoko Fujiwara; Yoshinori Morita; Takashi Toyonaga; Fumi Kawakami; Tomoo Itoh; Masaru Yoshida; Hiromu Kutsumi; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2011-02-26       Impact factor: 7.527

4.  Preprocedural rabeprazole treatment before endoscopic submucosal dissection for gastric neoplasms.

Authors:  Myong Ki Baeg; Myung-Gyu Choi; Seong Jin Moon; Chul-Hyun Lim; Jin Su Kim; Yu Kyung Cho; Jae Myung Park; In Seok Lee; Sang Woo Kim; Kyu Yong Choi
Journal:  Dig Dis Sci       Date:  2014-03-27       Impact factor: 3.199

5.  Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia.

Authors:  Hiroyuki Imaeda; Naoki Hosoe; Hidekazu Suzuki; Yoshimasa Saito; Yosuke Ida; Rieko Nakamura; Yasushi Iwao; Haruhiko Ogata; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2011-07-30       Impact factor: 7.527

6.  Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers.

Authors:  Masaki Takayama; Shigenaga Matsui; Masanori Kawasaki; Yutaka Asakuma; Toshiharu Sakurai; Hiroshi Kashida; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

7.  Effect of ilaprazole on the healing of endoscopic submucosal dissection-induced gastric ulcer: randomized-controlled, multicenter study.

Authors:  Chang Seok Bang; Woon Geon Shin; Seung In Seo; Min Ho Choi; Hyun Joo Jang; Se Woo Park; Sea Hyub Kae; Young Joo Yang; Suk Pyo Shin; Gwang Ho Baik; Hak Yang Kim
Journal:  Surg Endosc       Date:  2018-08-30       Impact factor: 4.584

8.  Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial.

Authors:  Daisuke Kawai; Ryuta Takenaka; Mikako Ishiguro; Shotaro Okanoue; Tatsuhiro Gotoda; Yoshiyasu Kono; Koji Takemoto; Hirofumi Tsugeno; Shigeatsu Fujiki
Journal:  BMC Gastroenterol       Date:  2021-05-22       Impact factor: 3.067

9.  Routine mucosal closure with a detachable snare and clips after endoscopic submucosal dissection for gastric epithelial neoplasms: a randomized controlled trial.

Authors:  Bo-In Lee; Byung-Wook Kim; Hyung-Keun Kim; Hwang Choi; Jeong-Seon Ji; Sun-Mee Hwang; Young-Seok Cho; Hiun-Suk Chae; Kyu-Yong Choi
Journal:  Gut Liver       Date:  2011-11-21       Impact factor: 4.519

10.  Comparative efficacy of various anti-ulcer medications after gastric endoscopic submucosal dissection: a systematic review and network meta-analysis.

Authors:  Eun Hye Kim; Se Woo Park; Eunwoo Nam; Jae Gon Lee; Chan Hyuk Park
Journal:  Surg Endosc       Date:  2018-08-30       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.